Montz Harcus Wealth Management LLC Bristol Myers Squibb CO Transaction History

Montz Harcus Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $37,512 - $41,945	-648 Reduced 14.82%	3,723 $216,000
Q2 2023 Jul 21, 2023	BUY	$63.71 - $70.74 $56,192 - $62,392	882 Added 25.28%	4,371 $279,000
Q1 2023 Apr 25, 2023	BUY	$65.71 - $74.53 $1,445 - $1,639	22 Added 0.63%	3,489 $241,000
Q4 2022 Jan 20, 2023	BUY	$68.48 - $81.09 $1,369 - $1,621	20 Added 0.58%	3,467 $0
Q3 2022 Nov 02, 2022	BUY	$0.13 - $76.84 $2 - $1,536	20 Added 0.58%	3,447 $245,000
Q2 2022 Jul 18, 2022	BUY	$72.62 - $79.98 $14,306 - $15,756	197 Added 6.1%	3,427 $264,000
Q1 2022 May 05, 2022	BUY	$61.48 - $73.72 $198,580 - $238,115	3,230 New	3,230 $236,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Montz Harcus Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Montz Harcus Wealth Management LLC with notifications on news.